One of the major problems associated with development of biologics is product stability, especially protein aggregation, denaturation and degradation.
HTD Biosystems provides contract development of biotech drugs including proteins, monoclonal antibodies, vaccines and liposomes, lyophilized products and stable liquid formulations for parenteral or oral delivery. In addition to formulation development of your molecule into a final product, HTD will help you with every aspects of your drug development including preformulation studies, formulation development, stability studies, scale up , tech transfer, analytical characterization and product and process development.
“HTD completed a rather complex project on time and within budget. HTD team brought a good balance of detailed planning and big picture thinking together which was key to the project success. Given the positive outcome, I was very satisfied with the work.”
Director of Manufacturing Technology, Large Biopharmaceutical Company
Smart Formulations & Delivery Systems
Accelerating Drug Development
Member of Bio | A Sponsor of American Association of Pharmaceutical Scientists Bay Area Discussion Group |
Design & Development of smart delivery systems for delivering antibodies, immunotherapy medicines,
anti-cancer drugs, antigens, vaccines, DNA and proteins.
Rational design and accelerated formulation of proteins and biologics
Using iFormulateTM , we help with rapid antibody screening and selection of the most stable formulation.